Previous 10 | Next 10 |
2023-10-13 13:36:57 ET Gainers: Sigma Additive Solutions ( SASI ) +138% . P & F Industries ( PFIN ) +87% . Bio-Path Holdings ( BPTH ) +61% . MicroAlgo ( MLGO ) +31% . Comtech Telecommunications Corp. ( CMTL ) +29% . PSQ H...
2023-10-13 12:14:05 ET DENVER, Colo., Oct. 13, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Sigma Additive Solutions (NASDAQ: SASI), Comtech Telecom (NASDAQ: CMTL), EHang Holdings Ltd (NASDAQ: E...
2023-10-13 10:07:01 ET DENVER, Colo., Oct. 13, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Sigma Additive Solutions (NASDAQ: SASI), EHang Holdings Ltd (NASDAQ: EH), Vertex Energy (NASDAQ: VTNR), Bio-P...
2023-10-13 09:32:40 ET DENVER, Colo., Oct 13, 2023 ( www.247marketnews.com )- Multiple listings are up big this morning, continuing this week’s trend. Of this morning’s momentum runners, Bio-Path Holdings Inc (NASDAQ: BPTH) may have the best chart and technical setup. ...
HOUSTON, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize ® liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced that Peter Nielsen,...
Dallas, Texas--(Newsfile Corp. - August 30, 2023) - Bio-Path Holdings, Inc. (NASDAQ: BPTH): Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (NASDAQ: BPTH) for Q2 2023. The full report can be accessed by clicking on the following link: BPTH Q2 23 Report To view the full...
2023-08-15 13:44:07 ET Bio-Path Holdings, Inc. (BPTH) Q2 2023 Results Conference Call August 15, 2023 08:30 AM ET Company Participants Will O'Connor - Investor Relations, Stern IR Peter Nielsen - President and Chief Executive Officer Anthony Price - Senior Vice P...
2023-08-15 07:01:40 ET Bio-Path press release ( NASDAQ: BPTH ): Q2 GAAP EPS of -$0.53 misses by $0.01 . As of June 30, 2023, the Company had cash of $3.4 million, compared to $10.4 million as of December 31, 2022. Net cash used in operating activities for the six m...
HOUSTON, Aug. 15, 2023 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnology company leveraging its proprietary DNAbilize ® liposomal delivery and antisense technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced its financial result...
HOUSTON, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio of targeted nucleic acid cancer drugs, today announced that it will host a...
News, Short Squeeze, Breakout and More Instantly...
Bio-Path Holdings Inc. Company Name:
BPTH Stock Symbol:
NASDAQ Market:
Bio-Path Holdings Inc. Website:
Marks Meaningful Progress Across Key Clinical Trials in Multiple Cancer Indications Completes Development of Oncology Molecular Biomarkers and Prepares for Preclinical Obesity Studies HOUSTON, July 08, 2024 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ:BPTH), a biotechnolog...
2024-06-17 10:10:00 ET June 17, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform releases the first of a two-part series looking at developments for the treatment of blood cancers. Today's snapshot focuses in on acute myeloid leukemia (AML) and the compan...